Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Baudin

Showing results (131-140 of 241) with videos related to

Pageof 25
Sort By:
Journal of Neuroendocrinology|April 6, 2026
European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoidsEric Baudin, Alice Durand, Wieneke Buikhuisen, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|November 15, 2018
Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours RegistryMatthias Kroiss, Timo Deutschbein, Wiebke Schlötelburg, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2011
Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter studyIlse G Hermsen, Martin Fassnacht, Massimo Terzolo, et al.
Hormones & Cancer|July 28, 2017
Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma PatientsJulien Hadoux, Marie Terroir, Sophie Leboulleux, et al.
European Journal of Endocrinology|February 9, 2013
Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemiaValérie Bernard, Catherine Lombard-Bohas, Marie-Caroline Taquet, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 2017
Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoidsIvana Sullivan, Gwénaël Le Teuff, Joël Guigay, et al.
Endocrine|August 28, 2023
Impact of lymphovascular invasion on otherwise low-risk papillary thyroid carcinomas: a retrospective and observational studyFrancisca Marques Puga, Abir Al Ghuzlan, Dana M Hartl, et al.
Thyroid : Official Journal of the American Thyroid Association|March 19, 2019
Redifferentiation of a <i>BRAF</i>-Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib TreatmentSophie Leboulleux, Corinne Dupuy, Ludovic Lacroix, et al.
Endocrine-Related Cancer|July 2, 2010
Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinomaPasqualino Malandrino, Abir Al Ghuzlan, Marine Castaing, et al.
Neuroendocrinology|October 23, 2019
Post-Radiation Grade 3 Neuroendocrine Carcinoma: A New Entity?Julien Hadoux, Pierre Blanchard, Jean-Yves Scoazec, et al.
Pageof 25

Showing results (131-140 of 241) with videos related to

Sort By:
Pageof 25
Journal of Neuroendocrinology|April 6, 2026
European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoidsEric Baudin, Alice Durand, Wieneke Buikhuisen, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|November 15, 2018
Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours RegistryMatthias Kroiss, Timo Deutschbein, Wiebke Schlötelburg, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2011
Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter studyIlse G Hermsen, Martin Fassnacht, Massimo Terzolo, et al.
Hormones & Cancer|July 28, 2017
Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma PatientsJulien Hadoux, Marie Terroir, Sophie Leboulleux, et al.
European Journal of Endocrinology|February 9, 2013
Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemiaValérie Bernard, Catherine Lombard-Bohas, Marie-Caroline Taquet, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 2017
Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoidsIvana Sullivan, Gwénaël Le Teuff, Joël Guigay, et al.
Endocrine|August 28, 2023
Impact of lymphovascular invasion on otherwise low-risk papillary thyroid carcinomas: a retrospective and observational studyFrancisca Marques Puga, Abir Al Ghuzlan, Dana M Hartl, et al.
Thyroid : Official Journal of the American Thyroid Association|March 19, 2019
Redifferentiation of a <i>BRAF</i>-Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib TreatmentSophie Leboulleux, Corinne Dupuy, Ludovic Lacroix, et al.
Endocrine-Related Cancer|July 2, 2010
Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinomaPasqualino Malandrino, Abir Al Ghuzlan, Marine Castaing, et al.
Neuroendocrinology|October 23, 2019
Post-Radiation Grade 3 Neuroendocrine Carcinoma: A New Entity?Julien Hadoux, Pierre Blanchard, Jean-Yves Scoazec, et al.
Pageof 25